Glucagon-like Peptide-1 Receptor Activation Reduces Pulmonary Vein Arrhythmogenesis and Regulates Calcium Homeostasis

Glucagon-like peptide-1 (GLP-1) receptor agonists are associated with reduced atrial fibrillation risk, but the mechanisms underlying this association remain unclear. The GLP-1 receptor agonist directly impacts cardiac Ca<sup>2+</sup> homeostasis, which is crucial in pulmonary vein (PV,...

Full description

Bibliographic Details
Main Authors: Chao-Shun Chan, Fong-Jhih Lin, Yao-Chang Chen, Yung-Kuo Lin, Satoshi Higa, Shih-Ann Chen, Yi-Jen Chen
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/17/13100
_version_ 1797582431481495552
author Chao-Shun Chan
Fong-Jhih Lin
Yao-Chang Chen
Yung-Kuo Lin
Satoshi Higa
Shih-Ann Chen
Yi-Jen Chen
author_facet Chao-Shun Chan
Fong-Jhih Lin
Yao-Chang Chen
Yung-Kuo Lin
Satoshi Higa
Shih-Ann Chen
Yi-Jen Chen
author_sort Chao-Shun Chan
collection DOAJ
description Glucagon-like peptide-1 (GLP-1) receptor agonists are associated with reduced atrial fibrillation risk, but the mechanisms underlying this association remain unclear. The GLP-1 receptor agonist directly impacts cardiac Ca<sup>2+</sup> homeostasis, which is crucial in pulmonary vein (PV, the initiator of atrial fibrillation) arrhythmogenesis. This study investigated the effects of the GLP-1 receptor agonist on PV electrophysiology and Ca<sup>2+</sup> homeostasis and elucidated the potential underlying mechanisms. Conventional microelectrodes and whole-cell patch clamp techniques were employed in rabbit PV tissues and single PV cardiomyocytes before and after GLP-1 (7-36) amide, a GLP-1 receptor agonist. Evaluations were conducted both with and without pretreatment with H89 (10 μM, an inhibitor of protein kinase A, PKA), KN93 (1 μM, an inhibitor of Ca<sup>2+</sup>/calmodulin-dependent protein kinase II, CaMKII), and KB-R7943 (10 μM, an inhibitor of Na<sup>+</sup>/Ca<sup>2+</sup> exchanger, NCX). Results showed that GLP-1 (7-36) amide (at concentrations of 1, 10, and 100 nM) reduced PV spontaneous activity in a concentration-dependent manner without affecting sinoatrial node electrical activity. In single-cell experiments, GLP-1 (7-36) amide (at 10 nM) reduced L-type Ca<sup>2+</sup> current, NCX current, and late Na<sup>+</sup> current in PV cardiomyocytes without altering Na<sup>+</sup> current. Additionally, GLP-1 (7-36) amide (at 10 nM) increased sarcoplasmic reticulum Ca<sup>2+</sup> content in PV cardiomyocytes. Furthermore, the antiarrhythmic effects of GLP-1 (7-36) amide on PV automaticity were diminished when pretreated with H89, KN93, or KB-R7943. This suggests that the GLP-1 receptor agonist may exert its antiarrhythmic potential by regulating PKA, CaMKII, and NCX activity, as well as modulating intracellular Ca<sup>2+</sup> homeostasis, thereby reducing PV arrhythmogenesis.
first_indexed 2024-03-10T23:22:12Z
format Article
id doaj.art-04979443ccc84522b539be8040f19f38
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T23:22:12Z
publishDate 2023-08-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-04979443ccc84522b539be8040f19f382023-11-19T08:12:26ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-08-0124171310010.3390/ijms241713100Glucagon-like Peptide-1 Receptor Activation Reduces Pulmonary Vein Arrhythmogenesis and Regulates Calcium HomeostasisChao-Shun Chan0Fong-Jhih Lin1Yao-Chang Chen2Yung-Kuo Lin3Satoshi Higa4Shih-Ann Chen5Yi-Jen Chen6Division of Cardiology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, TaiwanGraduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei 11031, TaiwanDepartment of Biomedical Engineering, National Defense Medical Center, Taipei 11490, TaiwanDivision of Cardiology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, TaiwanCardiac Electrophysiology and Pacing Laboratory, Division of Cardiovascular Medicine, Makiminato Central Hospital, Okinawa 9012131, JapanHeart Rhythm Center, Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei 11217, TaiwanDivision of Cardiology, Department of Internal Medicine, Wan-Fang Hospital, Taipei Medical University, Taipei 11696, TaiwanGlucagon-like peptide-1 (GLP-1) receptor agonists are associated with reduced atrial fibrillation risk, but the mechanisms underlying this association remain unclear. The GLP-1 receptor agonist directly impacts cardiac Ca<sup>2+</sup> homeostasis, which is crucial in pulmonary vein (PV, the initiator of atrial fibrillation) arrhythmogenesis. This study investigated the effects of the GLP-1 receptor agonist on PV electrophysiology and Ca<sup>2+</sup> homeostasis and elucidated the potential underlying mechanisms. Conventional microelectrodes and whole-cell patch clamp techniques were employed in rabbit PV tissues and single PV cardiomyocytes before and after GLP-1 (7-36) amide, a GLP-1 receptor agonist. Evaluations were conducted both with and without pretreatment with H89 (10 μM, an inhibitor of protein kinase A, PKA), KN93 (1 μM, an inhibitor of Ca<sup>2+</sup>/calmodulin-dependent protein kinase II, CaMKII), and KB-R7943 (10 μM, an inhibitor of Na<sup>+</sup>/Ca<sup>2+</sup> exchanger, NCX). Results showed that GLP-1 (7-36) amide (at concentrations of 1, 10, and 100 nM) reduced PV spontaneous activity in a concentration-dependent manner without affecting sinoatrial node electrical activity. In single-cell experiments, GLP-1 (7-36) amide (at 10 nM) reduced L-type Ca<sup>2+</sup> current, NCX current, and late Na<sup>+</sup> current in PV cardiomyocytes without altering Na<sup>+</sup> current. Additionally, GLP-1 (7-36) amide (at 10 nM) increased sarcoplasmic reticulum Ca<sup>2+</sup> content in PV cardiomyocytes. Furthermore, the antiarrhythmic effects of GLP-1 (7-36) amide on PV automaticity were diminished when pretreated with H89, KN93, or KB-R7943. This suggests that the GLP-1 receptor agonist may exert its antiarrhythmic potential by regulating PKA, CaMKII, and NCX activity, as well as modulating intracellular Ca<sup>2+</sup> homeostasis, thereby reducing PV arrhythmogenesis.https://www.mdpi.com/1422-0067/24/17/13100glucagon-like peptide-1 receptor agonistatrial fibrillationpulmonary vein
spellingShingle Chao-Shun Chan
Fong-Jhih Lin
Yao-Chang Chen
Yung-Kuo Lin
Satoshi Higa
Shih-Ann Chen
Yi-Jen Chen
Glucagon-like Peptide-1 Receptor Activation Reduces Pulmonary Vein Arrhythmogenesis and Regulates Calcium Homeostasis
International Journal of Molecular Sciences
glucagon-like peptide-1 receptor agonist
atrial fibrillation
pulmonary vein
title Glucagon-like Peptide-1 Receptor Activation Reduces Pulmonary Vein Arrhythmogenesis and Regulates Calcium Homeostasis
title_full Glucagon-like Peptide-1 Receptor Activation Reduces Pulmonary Vein Arrhythmogenesis and Regulates Calcium Homeostasis
title_fullStr Glucagon-like Peptide-1 Receptor Activation Reduces Pulmonary Vein Arrhythmogenesis and Regulates Calcium Homeostasis
title_full_unstemmed Glucagon-like Peptide-1 Receptor Activation Reduces Pulmonary Vein Arrhythmogenesis and Regulates Calcium Homeostasis
title_short Glucagon-like Peptide-1 Receptor Activation Reduces Pulmonary Vein Arrhythmogenesis and Regulates Calcium Homeostasis
title_sort glucagon like peptide 1 receptor activation reduces pulmonary vein arrhythmogenesis and regulates calcium homeostasis
topic glucagon-like peptide-1 receptor agonist
atrial fibrillation
pulmonary vein
url https://www.mdpi.com/1422-0067/24/17/13100
work_keys_str_mv AT chaoshunchan glucagonlikepeptide1receptoractivationreducespulmonaryveinarrhythmogenesisandregulatescalciumhomeostasis
AT fongjhihlin glucagonlikepeptide1receptoractivationreducespulmonaryveinarrhythmogenesisandregulatescalciumhomeostasis
AT yaochangchen glucagonlikepeptide1receptoractivationreducespulmonaryveinarrhythmogenesisandregulatescalciumhomeostasis
AT yungkuolin glucagonlikepeptide1receptoractivationreducespulmonaryveinarrhythmogenesisandregulatescalciumhomeostasis
AT satoshihiga glucagonlikepeptide1receptoractivationreducespulmonaryveinarrhythmogenesisandregulatescalciumhomeostasis
AT shihannchen glucagonlikepeptide1receptoractivationreducespulmonaryveinarrhythmogenesisandregulatescalciumhomeostasis
AT yijenchen glucagonlikepeptide1receptoractivationreducespulmonaryveinarrhythmogenesisandregulatescalciumhomeostasis